California researchers develop blood-filtering therapy for preeclampsia

Preeclampsia is a deadly pregnancy complication that threatens the lives of both pregnant women and their fetuses, particularly in very preterm cases.

For generations, preeclampsia has confronted medicine with a cruel dilemma — endanger the mother or endanger the child — and medicine has largely answered with silence. Now, researchers in California have published early evidence of a blood-filtering therapy that removes the specific protein driving the disease's destruction, suggesting that a third path between those two grim choices may at last be within reach. The findings, published in Nature, are preliminary, but they arrive into a void where no targeted treatment has ever existed, and that absence alone gives them weight.

California researchers develop blood-filtering therapy for preeclampsia

Related Coverage

Get The Register in your inbox